Amino Technologies – H1 adjusted earnings approaching 60% lower so why only a modest share price decline?
Amino Technologies (AMO) has announced results for its half year ended 31st May 2018, emphasising “strong revenue visibility and pipeline coverage - full year expectations confirmed” - the numbers though showing adjusted earnings approaching 60% lower than in the corresponding half in the prior year on revenue 17% lower at $41.2 million. Hmmm…
- By Steve Moore |
- 17 July 2018, 16:04 |
premium content
Now about that Cloudtag subsidiary wound up by the taxman a few days ago…
Amit Ben Haim does not like to be at the helm when one of his enterprises goes belly up. He always quits and leaves a gent called Massimo Ventimiglia to pick up the pieces. And hence we come to Cloudtag (CTAG) subsidiary CT Technology Services.
- By Tom Winnifrith |
- 17 July 2018, 15:42 |
Cloudcall – H1 “played out largely as we expected”. Hmmm, did it?
Previously writing on Cloudcall (CALL) it was 2017 results, emphasises significant reduction in cash burn… but is there?, with the shares more than 6% lower, towards 165p. Today a half-year trading update – and the shares currently down around 10%, at circa 140p…
- By Steve Moore |
- 17 July 2018, 13:59 |
premium content
Fatso Baldry – when’s the Westminster Group bailout placing & at what price?
Shares in Westminster Group (WSG), run by loathsome ex Tory MP slug, Tony “fatso” Baldry of 3DM infamy have slipped again to just 9.2p to sell. Those who ponied up £750,000 in the last bailout placing at 22p, less than six months ago, must by now realise that backing a Baldry run company is financial hara kiri. But things are going to get worse. You see the money's almost gone....
- By Tom Winnifrith, The Sheriff of AIM |
- 17 July 2018, 13:33 |
Image Scan – “pleased to announce” acquisition… but accompanying placing is far less pleasing!
Shares in Image Scan Holdings (IGE) reached approaching 13p last year and were 6p+ following half-year results in April before sliding in the last month, last closing at 5.5p. Now an “Acquisition and Proposed Placing” announcement…
- By Steve Moore |
- 17 July 2018, 11:08 |
premium content
Barclays - freebie advice to the board: don't do it!
Not much has got me fired up so far this week looking at the various regulatory disclosures but I did notice an article in the newspaper that purports to be America's leading financial journal yesterday with the worrisome headline of 'Barclays Mulls U.S. Push as Activist Looms...Executives debate whether greater exposure to the U.S. retail market could both generate revenues and fund its U.S. operations more efficiently'…
- By Chris Bailey |
- 17 July 2018, 09:50 |
premium content
Winnileaks: Julie Meyer lies to a judge & blames others in the Start Up Loans Case (which she lost)
Maybe Julie "Lingerie on expenses" Meyer MBE thought Winnileaks was on holiday. Winnileaks never rests. Our latest document shows Julie playing fast and loose with the truth as she ballted to avoid facing justice against the Start Up Loans Company.
- By Tom Winnifrith |
- 17 July 2018, 09:32 |
Video: Gold due a relief rally but bigger move is on hold
In this week's video update from Palisade Capital and the only technical analyst we give any time to at all, Jordan Roy Burne discusses where the market is and why it failed to break-out. Traders were anticipating a breakout, and many are likely disappointed. The dollar is consolidating and now above the long-term moving average. Concerning GDX and GDX.J, things are still pretty dull. Jordan warns that “Silver is also on the verge of breaking down out of a triangle.”
- By Tom Winnifrith |
- 17 July 2018, 09:11 |
Two Treatments for Rare Conditions Could Cure Amryt's Unfairly Low Share Price
Hello Share Chewers. Small pioneering medical companies are a favourite of mine. As finding a cure for a condition which is so often overlooked by the giant pharmas has to be a good thing. Both from the point of view of patients and that of shareholders.
- By Malcolm Stacey |
- 17 July 2018, 08:10 |
2018 UK Investor Show ‘Dragon’s Den’ monthly update - Tom still the leader?
The great success that was the 2018 UK Investor Show saw six 'Dragon's Den' sessions where a number of CEOs each gave a 1 minute (well, supposed to be!) pitch and three 'Dragons' at each session each picked a stock for a £1,000 investment. With the show having been in April, here’s a third performance update...
- By Steve Moore |
- 16 July 2018, 16:44 |
premium content
Tom Winnifrith Bearcast, Amur, Pantheon, Comrade Corbyn and the Brexit farce imponderable
I have no idea how the Brexit farce will pan out and who indeed will be PM this time next year. But it could well be Comrade Corbyn running a coalition of chaos. How will that play out on the markets this autumn and where will that leave those with no cash needing to raise money? In that vein I look at Amur Minerals (AMC) and Pantheon Resources (PANR). This bearcast has been delayed by a sweaty and lazy Bulgar as I explain here
- By Tom Winnifrith |
- 16 July 2018, 16:33 |
CyanConnode – “pleased to announce” a latest order. Hmmm - how’s that balance sheet?
CyanConnode (CYAN) has updated that it, “the world leader in narrowband radio mesh networks, announces receipt of a purchase order from HM Power for a smart metering implementation for a Swedish utility”. This follows also since I previously wrote last month the company having “officially launched its cost-optimised standards-based Omnimesh smart metering application at Asia Utility Week in Bangkok”. Building momentum then? Er…
- By Steve Moore |
- 16 July 2018, 15:50 |
Integumen – argues agreement with “a compelling strategic and financial rationale”, but is the (discounted) placing enough?
Shares in Integumen (SKIN) are currently 17.5% lower, at 0.70p, on restoration to trading on AIM despite it considering an “investment and licence agreement have a compelling strategic and financial rationale”. Hmmm…
- By Steve Moore |
- 16 July 2018, 13:51 |
Don’t confuse easy money with your own financial brilliance - Easy Is Over
You would never know it listening to the market cheerleaders but asset prices, both real and financial, are, once again, at extreme valuation levels relative to the trend economy. The valuation reality coupled with the prevailing, but false, “don’t worry” market narrative sets us up for another major financial crisis. A third major crisis in 20 years, but these are only supposed to happen once in every 100 or 1,000 or 10,000 years, so say the Central Bank models.
- By David Scott |
- 16 July 2018, 12:03 |
Plant Health Care – “on track to achieve full year revenue expectations”… so why a share price slump?
A trading statement from Plant Health Care (PHC) firstly emphasises “on track to achieve full year revenue expectations, which would represent 30% growth over 2017”. So why currently a 33% share price slump, to around 15p?...
- By Steve Moore |
- 16 July 2018, 11:10 |
premium content
Block Energy has interesting assets and is funded - speculative buy
These days it often seems to be the case that if you are interested in a new IPO, it is better to wait until that company has listed and the dust has settled, as often you will get a chance to buy in cheaper than those taking part in the initial fundraise. Block Energy (BLOE) looks to be one such outfit and the timing of its listing looks good, with the oil sector showing strength, plus there is plenty of potential from gas as well.
- By Gary Newman |
- 16 July 2018, 08:37 |
Minoan – loan facility extension as expected, real action imminent? YES!
Updating on Minoan Group (MIN) previously, we noted a loan from Hillside doesn’t seem a problem, with the company in constructive discussions to further extend to reflect the expectation of a successful sale of its Travel business in the near future. Now a “Loan Facility Extension” announcement…
- By HotStockRockets |
- 16 July 2018, 08:30 |
Such a High PE Suggests Caution for a Slowing Share Which Once Meant Massive Gains
Hello Share Shifters. We all know the legend of ASOS (ASC), or as it used to be known in the early days of internet shopping, As Seen On Screen. The share rose from about 7p to £12 quid and then went even better. Almost everyone I know in share trading, including me, admits to selling the share too early. But now I think that the ship has sailed and that to buy more shares now might not be such a good idea.
- By Malcolm Stacey |
- 16 July 2018, 08:20 |
premium content
Tom Winnifrith Bearcast - learning all the wrong lessons from Carillion
In today's bearcast I look at the range of utterly misguided reactions and proposals being made in the wake of the demise of Carillion (CLLN). Some folks just don't understand capitalism.
- By Tom Winnifrith |
- 15 July 2018, 10:42 |
Optibiotix chairman share purchase - £150,000 not to be ignored: STRONG BUY
Okay, the Optibiotix (OPTI) chairman does not get everything right. He is, after all shacked up with mad remoaning Tory MP Anna Soubry. But no-one is perfect. What we can say is that Neil Davidson has had a glittering business career so has a reputation to lose. His salary as Non Exec chairman will not make much difference to his net wealth but buying shares could.
- By HotStockRockets |
- 15 July 2018, 10:08 |